New pathways in the treatment for menopausal hot flushes

Affiliations

¹ Obstetrics and Gynaecology, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; Glasgow Royal Infirmary, Glasgow G31 2ER, UK. Electronic address: jenifer.sassarini@glasgow.ac.uk.
² MRC Centre for Reproductive Health, Queens Medical Research Institute, Edinburgh, UK.

Free article

Comment

Jenifer Sassarini et al. Lancet. 2017.

Free article

. 2017 May 6;389(10081):1775-1777.

doi: 10.1016/S0140-6736(17)30886-3. Epub 2017 Apr 3.

¹ Obstetrics and Gynaecology, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; Glasgow Royal Infirmary, Glasgow G31 2ER, UK. Electronic address: jenifer.sassarini@glasgow.ac.uk.
² MRC Centre for Reproductive Health, Queens Medical Research Institute, Edinburgh, UK.

No abstract available

Comment on

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
Prague JK, Roberts RE, Comninos AN, Clarke S, Jayasena CN, Nash Z, Doyle C, Papadopoulou DA, Bloom SR, Mohideen P, Panay N, Hunter MS, Veldhuis JD, Webber LC, Huson L, Dhillo WS. Prague JK, et al. Lancet. 2017 May 6;389(10081):1809-1820. doi: 10.1016/S0140-6736(17)30823-1. Epub 2017 Apr 3. Lancet. 2017. PMID: 28385352 Free PMC article. Clinical Trial.